Quest Diagnostics (DGX) Reports In-Line Q2 EPS; Trims FY12 Revs Growth Outlook
Go back to Quest Diagnostics (DGX) Reports In-Line Q2 EPS; Trims FY12 Revs Growth Outlook| Quest Diagnostics (NYSE: DGX) | Delayed: 246.45 -1 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $247.45 | 52 Week High | $86.85 | |||
| Open | $246.52 | 52 Week Low | $59.66 | |||
| Day High | $247.63 | P/E | 46.41 | |||
| Day Low | $244.89 | EPS | $5.31 | |||
| Volume | 1,924,738 | |||||
